Assessing the association between DNA variants and disease has been used wi
dely to identify regions of the genome and candidate genes that contribute
to disease. However, there are numerous examples of associations that canno
t be replicated, which has led to scepticism about the utility of the appro
ach for common conditions. With the discovery of massive numbers of genetic
markers and the development of better tools for genotyping, association st
udies will inevitably proliferate. Now is the time to consider critically t
he design of such studies, to avoid the mistakes of the past and to maximiz
e their potential to identify new components of disease.